HighVista Strategies’s HOOKIPA Pharma HOOK Stock Holding History

HighVista Strategies’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,205	Closed	-$71K	–	89
2021 Q3	$71K	Buy	+1,205	New	+$87.4K	0.05%	123

Other funds holding HOOK

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighVista Strategies's HOOK Position: Q4 2021 in Review

HighVista Strategies sold out of HOOKIPA Pharma (HOOK) in Q4 2021, closing a stake of 1,205 shares — an estimated $71K sold.

HighVista Strategies first reported a position in HOOK in Q3 2021 and held it in 1 quarter. The position peaked at $71K in Q3 2021. 72 funds tracked by Wall St. Rank hold HOOK as of Q4 2021.

HighVista Strategies reported no remaining HOOKIPA Pharma position as of Q4 2021 after selling out during the quarter.
HighVista Strategies sold 1,205 HOOKIPA Pharma shares in Q4 2021, an estimated $71K.
HighVista Strategies first reported a position in HOOKIPA Pharma in Q3 2021 and held it in 1 quarter.
HighVista Strategies's HOOKIPA Pharma position peaked at $71K in Q3 2021.
72 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.